Γ

SynBioBeta Speaker

Piotr Byrski

molecule.one

CEO

Piotr Byrski is the co-founder and CEO of Molecule.one, which built Maria^TM, the world’s first AI Chemist to deliver autonomous research projects in organic chemistry. Maria’s frontier AI directs experiments in a dark, high throughput microliter-scale lab, and after automated results analysis, the data moves to Maria’s fast-growing, proprietary database comprising tens of millions of datapoints about more than 400,000 chemical reactions. Maria is already deployed commercially with CDMOs (incl. W. R. Grace), pharma companies, a frontier AI firm, and biotechs.

Sessions Featuring

Piotr

This Year

Breakout Session

4:30 PM

-

5:15 PM

Tools & Tech

Self-Driving Labs, AI, and Automation: A Practical Guide to Getting Started

AI-enabled, self-driving labs are still emerging, but their foundations are already transforming how teams design, run, and interpret experiments. This session offers a practical guide for scientists and R&D leaders who want to understand what can be done today — from tightening design–test–learn loops to reducing manual error and capturing early benefits of autonomous experimentation. Rather than presenting an unrealized future, speakers will focus on practical, real-world steps that give organizations a competitive edge as SDL capabilities evolve and mature. Speakers will explore what’s working, what’s not, and how autonomous lab systems are reshaping protein engineering, pathway optimization, and therapeutic design.

Breakout Session

4:30 PM

-

5:15 PM

Tools & Tech

Self-Driving Labs, AI, and Automation: A Practical Guide to Getting Started

AI-enabled, self-driving labs are still emerging, but their foundations are already transforming how teams design, run, and interpret experiments. This session offers a practical guide for scientists and R&D leaders who want to understand what can be done today — from tightening design–test–learn loops to reducing manual error and capturing early benefits of autonomous experimentation. Rather than presenting an unrealized future, speakers will focus on practical, real-world steps that give organizations a competitive edge as SDL capabilities evolve and mature. Speakers will explore what’s working, what’s not, and how autonomous lab systems are reshaping protein engineering, pathway optimization, and therapeutic design.

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include